Mỹ phê duyệt thuốc viên Molnupiravir điều trị COVID-19 tại nhà

Thế giới

Cơ quan quản lý dược phẩm và thực phẩm Mỹ ngày 23/12 đã phê duyệt thuốc viên kháng virus của Merck & Co, dùng trong điều trị COVID-19, có tên Molnupiravir.

Email Print twitter facebook

08:20 24/12/2021 GMT+7

Đọc nhiều

{publishtime}

{title}
{publishtime}
{title}
{lead}

{title}

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

(TTXVN/Vietnam+)

{name} - {time}

Trả lời

{body}

{name} - {time}

{body}